• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Patient education programs may reduce disability and symptoms of chronic pain

byDonika YakoubandAlex Chan
June 5, 2024
in Chronic Disease, Neurology, Psychiatry
Reading Time: 3 mins read
American Academy of Pediatrics recommends standards for adverse event disclosures
Share on FacebookShare on Twitter

1. Adults with chronic low back pain (CLBP) randomized into a 6-week pain intervention education program were observed to have significantly relieved burden of pain-related disability and overall pain intensity when combined with the physiotherapeutic standard of care.

2. Measures of self-reported well being also improved significantly more in the pain education group compared to the control group. 

Evidence Rating Level: 1 (Excellent)

Chronic low back pain (CLBP) is a pervasive condition contributing significantly to pain-related disability worldwide. Several factors are thought to contribute to the burden of CLBP, and pharmacological treatments and physiotherapeutic intervention alone are not believed to be sufficient. The incorporation of psychological strategies and pain education is thought to be crucial, but a lack of standardization and ethnocultural considerations are barriers to widespread implementation. Western countries quite readily embrace pain education programs, and some Eastern countries currently lack robust testing for culturally relevant CLBP curricula. The current randomized controlled trial assessed whether a structured pain education intervention could reduce disability and pain intensity compared to the standard of care. A total of 92 patients with CLBP (mean [SD] age, 42.3 [10.8] years) were recruited from the Sher-e-Kashmir Institute of Medical Sciences (SKIMS) and blindly randomized 1:1 to either the control group or intervention group. Both received 40-minute guideline-based physical therapy sessions, but the intervention group underwent face-to-face education modules exploring definitions of chronic pain, its neurophysiology, and neurobiological aspects (central sensitization, fear avoidance, and social factors affecting CLBP). Didactic sessions occurred twice weekly for the first 3 weeks, followed by question-and-answer sessions in weeks 4 and 5, and a brief education manual was provided at the conclusion of the 6th week. Pain intensity during different activities of daily living (ADLs) was measured on a 0-to-10 scale. Pain-related disability was assessed using the Roland Morris Disability Questionnaire (RMDQ). Measures of self-efficacy and coping were reported using the General Self-Efficacy Scale (GSE), and emotional wellbeing was measured using the World Health Organization (WHO) Five Well-Being Index (WHO-5). Post-intervention results demonstrate that disability burden (RMDQ) scores significantly improved in both groups, but between-group mean difference reflected greater improvements in the experimental group (a 54.2% decrease in disability for experimental group, versus a 6.8% decrease in the control group) with a large effect size (p < .001, Cohen’s d = 0.75). Pain intensity decreased in both groups, with significant main effect and large effect size between the groups post-intervention (p < 0.001, Cohen’s d = 0.82). Measures of well-being on the WHO-5 improved in favor of the pain education group, with a moderate effect size (p < 0.001, Cohen’s d = 0.58). Scores on the GSE scale were not affected by the treatment. A regression found that higher reports of RMDQ at baseline were associated with elevated disability at 6 weeks, and higher educational attainment was protective against disability post-intervention. Higher pain scale scores increased the odds of high pain intensity at 6 weeks by 1.69-fold, and higher self-efficacy, female sex, and higher age at baseline were associated with positive outcomes for well-being and self-efficacy. Overall, results suggest that integrating a pain education program with standard physiotherapeutic care enhanced outcomes for CLBP patients in India, and multi-centre trials should be conducted to improve the external validity of results. 

Click to read the study in PLOSONE

Image: PD

RELATED REPORTS

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

Brain-predicted age difference may reliably predict dementia progression

Diffusion-weighted imaging may aid in prognostication for intracerebral hemorrhage

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anesthesiologychronic diseasechronic painneurologypain medicine
Previous Post

Short-term androgen deprivation therapy does not improve survival in patients receiving postoperative radiotherapy for prostate cancer

Next Post

Eisai’s Leqembi wins accelerated U.S. approval and unlocks broader Medicare coverage for the drug

RelatedReports

Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Chronic Disease

Brain-predicted age difference may reliably predict dementia progression

August 19, 2026
No difference in mortality for intensive versus standard reduction in blood pressure in intracerebral hemorrhage: The ATACH-2 trial
Emergency

Diffusion-weighted imaging may aid in prognostication for intracerebral hemorrhage

August 18, 2026
Epidural corticosteroid injections provide only short-term radiculopathy pain relief
Chronic Disease

A neurostimulation intervention may improve pain in patients with chronic low back pain

August 17, 2026
Next Post

Eisai's Leqembi wins accelerated U.S. approval and unlocks broader Medicare coverage for the drug

#VisualAbstract: Semaglutide Improves Outcomes in Patients with Type 2 Diabetes and Chronic Kidney Disease

#VisualAbstract: Semaglutide Improves Outcomes in Patients with Type 2 Diabetes and Chronic Kidney Disease

Placebo formulation impacts effectiveness of pain control in osteoarthritis

Resistance training not superior to neuromuscular exercises for hip osteoarthritis

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.